Study Details
A Multicenter, Randomized, Open-Label, Controlled Study to Evaluate the Efficacy and Safety between Treatment with Solifenacin Succinate Tablets and Combination treatment with Estrogen and Solifenacin Succinate Tablets in Post-Menopause Female with Overactive Bladder
Clinicaltrials.gov ID
N/A
Astellas Study ID
XH-WXK-001
EudraCT ID
N/A
Condition
Overactive Bladder Disease
Phase
Phase 4
Age
18 Years - 75 Years
Sex
Female
Product
solifenacin succinate
Type
Interventional
Trial Dates
Jan 2012 - Sep 2013
Masking
None (Open Label)
Enrollment number
104
A Multicenter, Randomized, Open-Label, Controlled Study to Evaluate the Efficacy and Safety between Treatment with Solifenacin Succinate Tablets and Combination treatment with Estrogen and Solifenacin Succinate Tablets in Post-Menopause Female with Overactive Bladder
Study summary
Study documents
Get More Information
Would you like more information about clinical trial sites that are recruiting participants for A Multicenter, Randomized, Open-Label, Controlled Study to Evaluate the Efficacy and Safety between Treatment with Solifenacin Succinate Tablets and Combination treatment with Estrogen and Solifenacin Succinate Tablets in Post-Menopause Female with Overactive Bladder? Contact us by filling our your information to the right and we’ll respond to you.